Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2012-12-01

Determination of amantadine and rimantadine using a sensitive fluorescent probe.

Guang-Quan Wang, Yan-Fang Qin, Li-Ming Du, Jun-Fei Li, Xu Jing, Yin-Xia Chang, Hao Wu

Index: Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 98 , 275-81, (2012)

Full Text: HTML

Abstract

Amantadine hydrochloride (AMA) and rimantadine hydrochloride (RIM) are non-fluorescent in aqueous solutions. This property makes their determination through direct fluorescent method difficult. The competing reactions and the supramolecular interaction mechanisms between the two drugs and coptisine (COP) as they fight for occupancy of the cucurbit[7]uril (CB[7]) cavity, were studied using spectrofluorimetry, (1)H NMR, and molecular modeling calculations. Based on the significant quenching of the supramolecular complex fluorescence intensity, a fluorescent probe method of high sensitivity and selectivity was developed to determine AMA or RIM in their pharmaceutical dosage forms and in urine samples with good precision and accuracy. The linear range of the method was from 0.0040 to 1.0 μg mL(-1) with a detection limit ranging from 0.0012 to 0.0013 μg mL(-1). This shows that the proposed method has promising potential for therapeutic monitoring and pharmacokinetics and for clinical application.Copyright © 2012 Elsevier B.V. All rights reserved.


Related Compounds

Related Articles:

Exploring the proton conductance and drug resistance of BM2 channel through molecular dynamics simulations and free energy calculations at different pH conditions.

2013-01-31

[J. Phys. Chem. B 117(4) , 982-8, (2013)]

Cys-Loop Receptor Channel Blockers Also Block GLIC

2011-12-21

[Biophys. J. 101(12) , 2912-8, (2011)]

[Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].

2011-01-01

[Antibiot. Khimioter. 56(3-4) , 3-9, (2011)]

Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.

2011-01-01

[Molecules 16(12) , 10227-55, (2011)]

Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.

2012-08-01

[Antiviral Res. 95(2) , 172-81, (2012)]

More Articles...